Anti-miRNA103/107 encapsulated in transferrin-conjugated lipid nanoparticles crosses blood-brain barrier and reduces brain ischemic damage
MicroRNA (miRNA), by post-transcriptionally regulating the expression of genes involved in stroke response, represents important effectors in stroke pathophysiology. Recently, the 103/107 miRNA family emerged as a possible therapeutic target in stroke, as it controls the expression of sodium calcium...
Збережено в:
| Автори: | , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2024-03-01
|
| Серія: | Molecular Therapy: Nucleic Acids |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2162253124000180 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|